Bensler’s Sherwin-Williams SHW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$238K Hold
692
0.02% 179
2026
Q1
$222K Hold
692
0.02% 175
2025
Q4
$224K Sell
692
-24,380
-97% -$8.16M 0.02% 169
2025
Q3
$8.68M Buy
25,072
+88
+0.4% +$31K 0.9% 40
2025
Q2
$8.58M Buy
24,984
+706
+3% +$245K 0.96% 39
2025
Q1
$8.48M Buy
24,278
+1,020
+4% +$358K 1.06% 37
2024
Q4
$7.91M Buy
23,258
+427
+2% +$159K 0.94% 38
2024
Q3
$8.71M Buy
22,831
+671
+3% +$234K 1.1% 31
2024
Q2
$6.61M Buy
22,160
+1,432
+7% +$443K 0.89% 34
2024
Q1
$7.2M Buy
20,728
+1,948
+10% +$621K 1.04% 31
2023
Q4
$5.86M Buy
18,780
+2,892
+18% +$778K 0.97% 36
2023
Q3
$4.05M Buy
15,888
+1,440
+10% +$385K 0.78% 44
2023
Q2
$3.84M Buy
14,448
+973
+7% +$229K 0.73% 44
2023
Q1
$3.03M Buy
13,475
+1,266
+10% +$290K 0.61% 55
2022
Q4
$2.9M Buy
12,209
+651
+6% +$151K 0.64% 51
2022
Q3
$2.37M Buy
11,558
+355
+3% +$84.1K 0.56% 61
2022
Q2
$2.51M Buy
11,203
+509
+5% +$131K 0.6% 57
2022
Q1
$2.67M Buy
10,694
+1,463
+16% +$404K 0.56% 60
2021
Q4
$3.25M Buy
+9,231
New +$2.98M 0.91% 43

Other funds holding SHW

Bensler's SHW Position: Q2 2026 in Review

Bensler held its Sherwin-Williams (SHW) position steady in Q2 2026 at 692 shares worth $238K. The position accounts for 0.02% of the portfolio, ranked #179.

Bensler first reported a position in SHW in Q4 2021 and has held it in 19 quarters since. The position peaked at $8.71M in Q3 2024. 1,735 funds tracked by Wall St. Rank hold SHW as of Q2 2026.

  • Bensler held 692 shares of Sherwin-Williams worth $238K as of Q2 2026.
  • Bensler left its Sherwin-Williams share count unchanged in Q2 2026.
  • Sherwin-Williams made up 0.02% of Bensler's portfolio in Q2 2026, its #179 holding.
  • Bensler first reported a position in Sherwin-Williams in Q4 2021 and has held it in 19 quarters since.
  • Bensler's Sherwin-Williams position peaked at $8.71M in Q3 2024.
  • 1,735 funds tracked by Wall St. Rank held Sherwin-Williams as of Q2 2026.

Based on Bensler's 13F filing for Q2 2026, filed 23 Jul 2026.